CBMX Combimatrix Corp. (MM)

CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders, today announced that Mark McDonough, CEO of CombiMatrix, will be presenting at the upcoming 8th Annual OneMedForum Conference in San Francisco. Mr. McDonough's presentation will begin at 10:10 a.m. PST on Monday, January 12, at the San Francisco Marriott Marquis hotel.

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support for the highest quality of care – specializing in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix offers comprehensive testing services for the detection of abnormalities of genes at the DNA level beyond what can be identified through traditional technologies. The Company performs genetic testing utilizing microarray, FISH, PCR and G-Band chromosome analyses. Additional information about CombiMatrix is available at www.combimatrix.com or by calling 1-800-710-0624.

CONTACT: Company Contact:
         Mark McDonough
         President & CEO, CombiMatrix Corporation
         (949) 753-0624
         
         Investor Contact:
         Robert Flamm, Ph.D.
         Russo Partners, LLC
         (212) 845-4226
         robert.flamm@russopartnersllc.com
         
         Media Contact:
         David Schull or Lena Evans
         Russo Partners LLC
         (212) 845-4271
         david.schull@russopartnersllc.com
         lena.evans@russopartnersllc.com